Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT Available to Purchase

2.

Kolb

HJ

.

Graft-versus-leukemia effects of transplantation and donor lymphocytes

.

Blood

.

2008

;

112

(

12

):

4371

-

4383

.

3.

Malard

F

,

Holler

E

,

Sandmaier

BM

,

Huang

H

,

Mohty

M

.

Acute graft-versus-host disease

.

Nat Rev Dis Primers

.

2023

;

9

(

1

):

27

.

4.

Préville

X

,

Flacher

M

,

LeMauff

B

, et al.

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

.

Transplantation

.

2001

;

71

(

3

):

460

-

468

.

5.

Handschumacher

RE

,

Harding

MW

,

Rice

J

,

Drugge

RJ

,

Speicher

DW

.

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

.

Science

.

1984

;

226

(

4674

):

544

-

547

.

6.

Beilhack

A

,

Schulz

S

,

Baker

J

, et al.

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets

.

Blood

.

2005

;

106

(

3

):

1113

-

1122

.

7.

Beilhack

A

,

Schulz

S

,

Baker

J

, et al.

Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs

.

Blood

.

2008

;

111

(

5

):

2919

-

2928

.

8.

Bleakley

M

,

Sehgal

A

,

Seropian

S

, et al.

Naive T-cell depletion to prevent chronic graft-versus-host disease

.

J Clin Oncol

.

2022

;

40

(

11

):

1174

-

1185

.

9.

Huynh

ML

,

Fadok

VA

,

Henson

PM

.

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

.

J Clin Invest

.

2002

;

109

(

1

):

41

-

50

.

10.

Taylor

PR

,

Carugati

A

,

Fadok

VA

, et al.

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

.

J Exp Med

.

2000

;

192

(

3

):

359

-

366

.

11.

Fadok

VA

,

Bratton

DL

,

Konowal

A

,

Freed

PW

,

Westcott

JY

,

Henson

PM

.

Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF

.

J Clin Invest

.

1998

;

101

(

4

):

890

-

898

.

12.

Hanayama

R

,

Tanaka

M

,

Miyasaka

K

, et al.

Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice

.

Science

.

2004

;

304

(

5674

):

1147

-

1150

.

13.

Herrmann

M

,

Voll

RE

,

Zoller

OM

,

Hagenhofer

M

,

Ponner

BB

,

Kalden

JR

.

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

.

Arthritis Rheum

.

1998

;

41

(

7

):

1241

-

1250

.

14.

Genua

M

,

D'Alessio

S

,

Cibella

J

, et al.

The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation

.

Gut

.

2015

;

64

(

4

):

589

-

600

.

15.

Lee

HN

,

Tian

L

,

Bouladoux

N

, et al.

Dendritic cells expressing immunoreceptor CD300f are critical for controlling chronic gut inflammation

.

J Clin Invest

.

2017

;

127

(

5

):

1905

-

1917

.

16.

Chao

MP

,

Majeti

R

,

Weissman

IL

.

Programmed cell removal: a new obstacle in the road to developing cancer

.

Nat Rev Cancer

.

2011

;

12

(

1

):

58

-

67

.

17.

Oldenborg

PA

,

Zheleznyak

A

,

Fang

YF

,

Lagenaur

CF

,

Gresham

HD

,

Lindberg

FP

.

Role of CD47 as a marker of self on red blood cells

.

Science

.

2000

;

288

(

5473

):

2051

-

2054

.

18.

Olsson

M

,

Bruhns

P

,

Frazier

WA

,

Ravetch

JV

,

Oldenborg

PA

.

Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia

.

Blood

.

2005

;

105

(

9

):

3577

-

3582

.

19.

Blazar

BR

,

Lindberg

FP

,

Ingulli

E

, et al.

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells

.

J Exp Med

.

2001

;

194

(

4

):

541

-

549

.

20.

Chao

MP

,

Alizadeh

AA

,

Tang

C

, et al.

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

.

Cell

.

2010

;

142

(

5

):

699

-

713

.

21.

Willingham

SB

,

Volkmer

JP

,

Gentles

AJ

, et al.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

.

Proc Natl Acad Sci U S A

.

2012

;

109

(

17

):

6662

-

6667

.

22.

Jaiswal

S

,

Jamieson

CH

,

Pang

WW

, et al.

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

.

Cell

.

2009

;

138

(

2

):

271

-

285

.

23.

Majeti

R

,

Chao

MP

,

Alizadeh

AA

, et al.

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells

.

Cell

.

2009

;

138

(

2

):

286

-

299

.

24.

Lerbs

T

,

Cui

L

,

King

ME

, et al.

CD47 prevents the elimination of diseased fibroblasts in scleroderma

.

JCI Insight

.

2020

;

5

(

16

):

e140458

.

25.

Wang

Q

,

Onuma

K

,

Liu

C

, et al.

Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis

.

JCI Insight

.

2019

;

4

(

18

):

e128616

.

26.

Hashimoto

D

,

Chow

A

,

Greter

M

, et al.

Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation

.

J Exp Med

.

2011

;

208

(

5

):

1069

-

1082

.

27.

Beckett

AN

,

Chockley

P

,

Pruett-Miller

SM

, et al.

CD47 expression is critical for CAR T-cell survival in vivo

.

J Immunother Cancer

.

2023

;

11

(

3

):

e005857

.

28.

Yamada-Hunter

SA

,

Theruvath

J

,

McIntosh

BJ

, et al.

Engineered CD47 protects T cells for enhanced antitumour immunity

.

Nature

.

2024

;

630

(

8016

):

457

-

465

.

29.

Advani

R

,

Flinn

I

,

Popplewell

L

, et al.

CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin's lymphoma

.

N Engl J Med

.

2018

;

379

(

18

):

1711

-

1721

.

30.

Wang

H

,

Newton

G

,

Wu

L

, et al.

CD47 antibody blockade suppresses microglia-dependent phagocytosis and monocyte transition to macrophages, impairing recovery in EAE

.

JCI Insight

.

2021

;

6

(

21

):

e148719

.

31.

VanDussen

KL

,

Stojmirović

A

,

Li

K

, et al.

Abnormal small intestinal epithelial microvilli in patients with crohn's disease

.

Gastroenterology

.

2018

;

155

(

3

):

815

-

828

.

32.

Gardai

SJ

,

McPhillips

KA

,

Frasch

SC

, et al.

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

.

Cell

.

2005

;

123

(

2

):

321

-

334

.

33.

Naito

T

,

Takatsu

H

,

Miyano

R

,

Takada

N

,

Nakayama

K

,

Shin

HW

.

Phospholipid flippase ATP10A translocates phosphatidylcholine and is involved in plasma membrane dynamics

.

J Biol Chem

.

2015

;

290

(

24

):

15004

-

15017

.

34.

Barkal

AA

,

Brewer

RE

,

Markovic

M

, et al.

CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

.

Nature

.

2019

;

572

(

7769

):

392

-

396

.

35.

Zeiser

R

,

Nguyen

VH

,

Beilhack

A

, et al.

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

.

Blood

.

2006

;

108

(

1

):

390

-

399

.

36.

Bäuerlein

CA

,

Riedel

SS

,

Baker

J

, et al.

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model

.

BMC Med

.

2013

;

11

:

134

.

37.

Chen

YB

,

Kim

HT

,

McDonough

S

, et al.

Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation

.

Biol Blood Marrow Transplant

.

2009

;

15

(

9

):

1066

-

1076

.

38.

Bäuerlein

CA

,

Qureischi

M

,

Mokhtari

Z

, et al.

A T-cell surface marker panel predicts murine acute graft-versus-host disease

.

Front Immunol

.

2020

;

11

:

593321

.

39.

Ticchioni

M

,

Deckert

M

,

Mary

F

,

Bernard

G

,

Brown

EJ

,

Bernard

A

.

Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells

.

J Immunol

.

1997

;

158

(

2

):

677

-

684

.

40.

Oh

H

,

Grinberg-Bleyer

Y

,

Liao

W

, et al.

An NF-κB transcription-factor-dependent lineage-specific transcriptional program promotes regulatory T cell identity and function

.

Immunity

.

2017

;

47

(

3

):

450

-

465.e455

.

41.

Skene

PJ

,

Henikoff

S

.

An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites

.

Elife

.

2017

;

6

:

e21856

.

42.

Zeller

T

,

Lutz

S

,

Münnich

IA

, et al.

Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages

.

Front Immunol

.

2022

;

13

:

929339

.

43.

Shaikh

H

,

Pezoldt

J

,

Mokhtari

Z

, et al.

Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells

.

JCI Insight

.

2022

;

7

(

22

):

e154250

.

44.

Sikic

BI

,

Lakhani

N

,

Patnaik

A

, et al.

First-in-human, first-in-class phase I trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers

.

J Clin Oncol

.

2019

;

37

(

12

):

946

-

953

.

45.

Lavender

KJ

,

Pang

WW

,

Messer

RJ

, et al.

BLT-humanized C57BL/6 Rag2^-/-γc^-/-CD47^-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection

.

Blood

.

2013

;

122

(

25

):

4013

-

4020

.

46.

He

Y

,

Sun

X

,

Rong

W

, et al.

CD47 is a negative regulator of intestinal epithelial cell self-renewal following DSS-induced experimental colitis

.

Sci Rep

.

2020

;

10

(

1

):

10180

.

47.

Fortin

G

,

Raymond

M

,

Van

VQ

, et al.

A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells

.

J Exp Med

.

2009

;

206

(

9

):

1995

-

2011

.

48.

Van

VQ

,

Baba

N

,

Rubio

M

, et al.

CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice

.

PLoS One

.

2012

;

7

(

8

):

e41972

.

49.

Lindberg

FP

,

Bullard

DC

,

Caver

TE

,

Gresham

HD

,

Beaudet

AL

,

Brown

EJ

.

Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice

.

Science

.

1996

;

274

(

5288

):

795

-

798

.

50.

Guimont-Desrochers

F

,

Beauchamp

C

,

Chabot-Roy

G

, et al.

Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes

.

Int Immunol

.

2009

;

21

(

2

):

167

-

177

.

51.

Legrand

N

,

Huntington

ND

,

Nagasawa

M

, et al.

Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo

.

Proc Natl Acad Sci U S A

.

2011

;

108

(

32

):

13224

-

13229

.

52.

Piccio

L

,

Vermi

W

,

Boles

KS

, et al.

Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation

.

Blood

.

2005

;

105

(

6

):

2421

-

2427

.

53.

Pettersen

RD

,

Hestdal

K

,

Olafsen

MK

,

Lie

SO

,

Lindberg

FP

.

CD47 signals T cell death

.

J Immunol

.

1999

;

162

(

12

):

7031

-

7040

.

54.

Stefanidakis

M

,

Newton

G

,

Lee

WY

,

Parkos

CA

,

Luscinskas

FW

.

Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro

.

Blood

.

2008

;

112

(

4

):

1280

-

1289

.

55.

Dehmani

S

,

Nerriere-Daguin

V

,

Neel

M

, et al.

SIRPγ-CD47 interaction positively regulates the activation of human T cells in situation of chronic stimulation

.

Front Immunol

.

2021

;

12

:

732530

.

56.

Avice

MN

,

Rubio

M

,

Sergerie

M

,

Delespesse

G

,

Sarfati

M

.

CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors

.

J Immunol

.

2000

;

165

(

8

):

4624

-

4631

.

57.

Grimbert

P

,

Bouguermouh

S

,

Baba

N

, et al.

Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation

.

J Immunol

.

2006

;

177

(

6

):

3534

-

3541

.

58.

Vallejo

AN

,

Mügge

LO

,

Klimiuk

PA

,

Weyand

CM

,

Goronzy

JJ

.

Central role of thrombospondin-1 in the activation and clonal expansion of inflammatory T cells

.

J Immunol

.

2000

;

164

(

6

):

2947

-

2954

.

59.

Vieyra-Garcia

PA

,

Wolf

P

.

Extracorporeal photopheresis: a case of immunotherapy ahead of its time

.

Transfus Med Hemother

.

2020

;

47

(

3

):

226

-

235

.

60.

Morrissey

MA

,

Kern

N

,

Vale

RD

.

CD47 ligation repositions the inhibitory receptor SIRPA to suppress integrin activation and phagocytosis

.

Immunity

.

2020

;

53

(

2

):

290

-

302.e6

.

61.

Hunter

CA

,

Kastelein

R

.

Interleukin-27: balancing protective and pathological immunity

.

Immunity

.

2012

;

37

(

6

):

960

-

969

.

62.

Sabat

R

,

Grütz

G

,

Warszawska

K

, et al.

Biology of interleukin-10

.

Cytokine Growth Factor Rev

.

2010

;

21

(

5

):

331

-

344

.

63.

Tseng

D

,

Volkmer

JP

,

Willingham

SB

, et al.

Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response

.

Proc Natl Acad Sci U S A

.

2013

;

110

(

27

):

11103

-

11108

.

64.

Gao

Q

,

Zhang

Y

,

Han

C

, et al.

Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells

.

J Autoimmun

.

2016

;

69

:

74

-

85

.

65.

Daver

NG

,

Vyas

P

,

Kambhampati

S

, et al.

Tolerability and efficacy of the anticluster of differentiation 47 antibody magrolimab combined with azacitidine in patients with previously untreated AML: phase Ib results

.

J Clin Oncol

.

2023

;

41

(

31

):

4893

-

4904

.

66.

Thaker

YR

,

Rivera

I

,

Pedros

C

, et al.

A novel affinity engineered anti-CD47 antibody with improved therapeutic index that preserves erythrocytes and normal immune cells

.

Front Oncol

.

2022

;

12

:

884196

.

67.

Logtenberg

MEW

,

Jansen

JHM

,

Raaben

M

, et al.

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy

.

Nat Med

.

2019

;

25

(

4

):

612

-

619

.

68.

Lakhani

NJ

,

Chow

LQM

,

Gainor

JF

, et al.

Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

.

Lancet Oncol

.

2021

;

22

(

12

):

1740

-

1751

.